(Press-News.org) A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers. The treatment is based on a naturally occurring human enzyme that has been genetically modified to fool cancer cells into killing themselves.
The unique concept, patented by Wayne State University, was successfully demonstrated on melanoma cells that are resistant to routine treatments such as chemotherapy or radiotherapy. Melanoma is a perfect model for testing this new therapy because it is considered the most aggressive form of human cancer due to its many defense mechanisms against available treatments. The success of the therapy in killing melanoma suggests a similar outcome in treating other cancers.
Developed by Karli Rosner, M.D., Ph.D., assistant professor and director of Research in the Department of Dermatology, the method uses genetic constructs that contain a genetically modified enzyme -- DNase1 protein -- to seek out and destroy cancer cells. The novel technology was published in the article "Engineering a waste management enzyme to overcome cancer resistance to apoptosis: adding DNase1 to the anti-cancer toolbox" in the Jan. 14 online edition of Cancer Gene Therapy, a Nature Publishing Group journal.
Dr. Rosner modified the genetic code for DNase1, a highly potent DNA-degrading enzyme, and altered its genetic composition by deleting a part of the code, mutating another part and adding an artificial piece of code. Through these changes, the altered DNA program is translated into a modified protein. In contrast to the natural protein, the modified protein will not be eliminated from the cancer cell, will resist deactivation by cell inhibitors and will gain access to the cell's nucleus. "If you imagine the cell's nucleus as a computer and DNA in the nucleus as computer software," Dr. Rosner explained, "then the altered, hacked DNA program corresponds to a computer virus."
"To further understand this anti-cancer technology," he continued, "recollect the plot from the movie, Independence Day. In this movie, a computer virus is introduced into an alien ship to neutralize its defenses and make it vulnerable to external weapons. We do something similar but much better by introducing the altered genetic code of DNase1 into the DNA of cancer cells alien to the healthy body." The cancer cell, unaware of the destructive potential of the modified code, translates it into a protein that evades the cell's defense mechanisms and enters the nucleus. In the nucleus, the protein damages DNA by chopping it into fragments without the need for external weaponry, i.e., other medications. Following damage to DNA, the cell's organelles disintegrate and the cancer cell dies. In this way, Dr. Rosner's technology leads cancer cells into committing suicide because he fools them into generating the protein that will cause their own death.
The beauty of this therapy is that specifically-targeted cancer cells destroy themselves through the physiological mechanism of apoptosis, leaving surrounding healthy cells intact. This mode of cancer cell elimination leaves no residual debris to alert the immune system to kick in, essentially committing "the perfect crime," Dr. Rosner said. This is important because the many side effects of current anti-cancer treatments are attributed to activation of the immune system. The fact that this therapy does not require participation of the patient's immune system to kill cancer cells is a big advantage over other newly developed technologies, such as the cancer vaccine. Those technologies depend on the patient's immune system to destroy cancer. Unfortunately, they are not effective in the presence of a compromised immune system, which is true for many cancer patients. In contrast, Dr. Rosner's therapy will be able to treat even the most severely immuno-compromised patients with the same degree of success as in treating patients with a fully functional immune system.
Patients with the same cancer type vary in their response to identical treatment because the biological characteristics of the same cancer type usually differ between patients. As a result, the medical field strives to develop treatments that can be adjusted to each patient. The structure of Dr. Rosner's technology is flexible in that it contains Lego-like pieces that together form a genetic construct. Each piece can be replaced by one of several other genetic pieces that perform the same task, but differ slightly in their genetics. The multiple options available for each genetic piece will allow the physician to tailor the finalized treatment to each patient based on the unique characteristics of his or her cancer. In this way, the new technology is a "true personalized therapy" he said. The physician will expose a patient's cancer cells obtained by biopsy, to various genetic constructs to identify the version of therapy that kills the patient's cancer with the utmost efficiency.
Of particular importance is the potential for this technology to treat a large variety of tumors, such as prostate, lung and breast cancers. Dr. Rosner likened the therapy to the military's Tomahawk missile platform. The Tomahawk is directed to its target by programming the missile's homing device. Likewise, the destructive genetic construct can be targeted to a particular cancer type by incorporating a genetic piece that specifically identifies the cancer. Multiple genetic homing devices will be at the physician's disposal. The ability to target the therapy specifically to cancer cells will reduce side effects common with today's anti-cancer therapies. Moreover, the ability to target multiple cancers will immensely increase the number of cancer patients who will benefit from the new technology.
The one side effect that Dr. Rosner foresees is the potential for lightening of skin hue at a level that he cannot predict, but that's a tradeoff someone suffering from metastatic cancer and given a limited prognosis may accept in exchange for becoming cancer-free.
To date, Dr. Rosner has demonstrated cancer cell kill rates of 70 to 100 percent with his first generation of "gene suicide therapy." To further increase the killing efficiency, he has recently designed a second generation of constructs. In the near future he intends to test the therapy in an animal model, an intermediate step required before moving the treatment into clinical trial.
"Although this has been tested on melanoma cell lines, Dr. Rosner's approach can be tailored to other types of tumors," said Darius Mehregan, M.D., the Hermann Pinkus Chair of the Department of Dermatology. "I think it is important for other researchers in the Wayne State University system to be aware of possibilities to collaborate, and for the pharmaceutical industry to be aware of the economic potential of this novel technology."
###
To read the complete study, visit http://www.nature.com/cgt/journal/vaop/ncurrent/full/cgt201084a.html.
WSU researcher creates patented personalized therapy that causes cancer cells to kill themselves
2011-03-01
ELSE PRESS RELEASES FROM THIS DATE:
Human stem cells from fat tissue fuse with rat heart cells and beat
2011-03-01
If Dr. Doolittle is famous for talking to animals, then here's a story that might make him hold his tongue: According to new research published online in The FASEB Journal (http://www.fasebj.org), scientists have successfully fused human stem cells derived from subcutaneous adipose (fat) tissue with muscle cells from rat hearts. Not only did these cells "talk" to form new muscle cells altogether, but they actually beat.
"Recovery of regenerative cells located in the stromal vascular fraction of a patient's own subcutaneous tissue is relatively simple and can be used for ...
University of Maryland School of Medicine study identifies genes associated with binge drinking
2011-03-01
University of Maryland School of Medicine researchers have identified two genes associated with binge drinking that may open doors to new, more effective treatments for excessive alcohol drinking. The scientists found that manipulating two receptors in the brain, GABA receptors and toll-like receptor 4 (TLR4), "caused profound reduction" of binge drinking for two weeks in rodents that had been bred and trained to drink excessively. The study was published online the week of Feb. 28 in the journal the Proceedings of the National Academy of Sciences.
About 30 percent of ...
Intervention helps women manage weight during and after pregnancy
2011-03-01
PROVIDENCE, R.I. [Brown University] — Excessive weight gain isn't healthy at any stage of life, but during pregnancy it can do lasting harm to the mother and baby alike. Now researchers at Brown University and The Miriam Hospital are encouraged by a new study describing an intervention that helped pregnant women control their weight.
"This study suggests that a lifestyle intervention can help women manage their weight during pregnancy, prevent health problems during pregnancy, and reduce weight retention after having a baby," said study lead author Suzanne Phelan, adjunct ...
Gay rights movement born in 19th century Germany, scholar says
2011-03-01
Same-sex erotic relationships are as old as humanity, but our modern understanding of what it means to be homosexual—and the earliest gay rights movement—started in nineteenth-century Germany, according to an article by historian Robert Beachy from Goucher College.
The article, "The German Invention of Homosexuality," is published in a recent issue of The Journal of Modern History. Beachy's book on the subject, Gay Berlin: Birthplace of a Modern Identity (Knopf), is due out next year.
According to Beachy, modern conceptions of homosexuality began, ironically, with an ...
New peptide could be effective treatment for triple negative breast cancer
2011-03-01
A new peptide developed by researchers in Temple University's College of Science and Technology has demonstrated efficacy against triple negative breast cancer.
The leptin receptor antagonist peptide, developed by researchers Laszlo Otvos and Eva Surmacz, could become an attractive option for triple negative breast cancer treatment, especially in the obese patient population. The researchers published their findings online in the European Journal of Cancer.
According to the researchers, triple-negative breast cancers—which represent 10 percent of all mammary ...
Development team achieves 1 terabit per second data rate on a single integrated photonic chip
2011-03-01
WASHINGTON, Feb. 28—With worldwide Internet data traffic increasing by 50 percent each year, telecommunications companies that handle this digital torrent must be able to economically expand the capacities of their networks while also adapting to new, more-efficient data-handling technologies. Over the last decade, a development team at Infinera Corp. in Sunnyvale, Calif. has pioneered the design and manufacture of photonic integrated circuits (PICs) aimed at meeting that need. This technology has enabled the team to achieve a record one trillion bits per second (1 Terabit/s) ...
Researchers develop curious snapshot of powerful retinal pigment and its partners
2011-03-01
BETHESDA, Md., Feb. 28, 2011 – Science fiction novelist and scholar Issac Asimov once said, "The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!' but 'That's funny.' " This recently rang true for an international team of researchers when they observed something they did not expect.
In a Journal of Biological Chemistry "Paper of the Week," the Berlin-based team reports that it has uncovered surprising new details about a key protein-protein interaction in the retina that contributes to the exquisite sensitivity of vision. ...
Full bladder, better decisions? Controlling your bladder decreases impulsive choices
2011-03-01
What should you do when you really, REALLY have to "go"? Make important life decisions, maybe. Controlling your bladder makes you better at controlling yourself when making decisions about your future, too, according to a study to be published in Psychological Science, a journal of the Association for Psychological Science.
Sexual excitement, hunger, thirst—psychological scientists have found that activation of just one of these bodily desires can actually make people want other, seemingly unrelated, rewards more. Take, for example, a man who finds himself searching ...
MIT-- parts of brain can switch functions
2011-03-01
Cambridge, MASS- When your brain encounters sensory stimuli, such as the scent of your morning coffee or the sound of a honking car, that input gets shuttled to the appropriate brain region for analysis. The coffee aroma goes to the olfactory cortex, while sounds are processed in the auditory cortex.
That division of labor suggests that the brain's structure follows a predetermined, genetic blueprint. However, evidence is mounting that brain regions can take over functions they were not genetically destined to perform. In a landmark 1996 study of people blinded early ...
Gut bacteria can control organ functions
2011-03-01
Bacteria in the human gut may not just be helping digest food but also could be exerting some level of control over the metabolic functions of other organs, like the liver, according to research published this week in the online journal mBio®. These findings offer new understanding of the symbiotic relationship between humans and their gut microbes and how changes to the microbiota can impact overall health.
"The gut microbiota enhances the host's metabolic capacity for processing nutrients and drugs and modulates the activities of multiple pathways in a variety of organ ...